Castle Biosciences CSTL
NASDAQ CSTL
$34.24 +1.08 (+3.27%)
As of: Oct 21, 2026 · 12:42 PM EDT

Castle Biosciences (CSTL) Revenue (2018 - 2026)

Updated

Castle Biosciences (CSTL) posted Revenue of $103.55 million for Q2 2026, up 20.1% from $86.19 million a year earlier and up 23.7% from the prior quarter.

Analysis

Castle Biosciences (CSTL) Revenue (2018 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Revenue at Castle Biosciences was $357.28 million, up 3.2% year-over-year; for FY2025, it came in at $344.23 million, up 3.7% from FY2024.

  • Annual Revenue has increased for seven consecutive years, with a five-year compound annual growth rate of 40.6% (FY2020 to FY2025).
  • In prior years, Castle Biosciences' Revenue was $332.07 million in FY2024 (+51.1%), $219.79 million in FY2023 (+60.4%), $137.04 million in FY2022 (+45.7%) and $94.09 million in FY2021 (+50.2%).
  • The Q2 2026 figure stands as the highest quarterly Revenue in data going back to Q2 2018.
  • On a year-over-year basis, Revenue increased in five of the last eight quarters, with growth averaging 12.8%.
  • The strongest year-over-year quarter for Revenue in the past five years was Q1 2024, with growth of 73.6%; the weakest was Q1 2026, with a decline of 4.9%.
  • According to Business Quant data, Revenue for the three prior quarters was $83.68 million (Q1 2026), $87.01 million (Q4 2025) and $83.04 million (Q3 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
API Access

Castle Biosciences Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=CSTL&period=max&api_key=YOUR_API_KEY